Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
XAIR Transcript
Beyond Air, Inc. (XAIR) Q4 2026 Earnings Call Transcript
Neutral6-26
Beyond Air, Inc. (XAIR) Q3 2026 Earnings Call Transcript
Positive2-13
The earnings call indicates positive developments: significant reduction in SG&A expenses, improved net loss, and strong cash position. The Q&A reveals strategic efforts in market penetration and international expansion, with optimistic guidance for FDA approval and partnerships. Although some concerns remain about sales cycle length and SG&A impact, the overall sentiment is positive, especially with international growth and financial improvements. The stock is likely to see a 2% to 8% increase over the next two weeks.
Beyond Air, Inc. (XAIR) Q2 2026 Earnings Call Transcript
Positive11-10
The earnings call summary indicates strong financial performance with a 128% YoY revenue increase, reduced gross losses, and significant cost reductions. The Q&A section reveals positive sentiment towards the second-gen LungFit PH, expected to drive further growth, despite supply chain challenges. The company's strategic international expansion and new business model also contribute positively. However, the vague management responses and updated guidance suggest some uncertainty, tempering the overall sentiment. Considering these factors, the stock price is likely to experience a positive movement, especially given the significant revenue growth and cost control.
Beyond Air, Inc. (XAIR) Q1 2026 Earnings Call Transcript
Positive8-12
The earnings call presents strong revenue growth, optimistic guidance, international expansion, and reduced expenses. The Q&A section reveals confidence in achieving guidance, despite some uncertainties in hospital contracts and PMA filings. Cash reserves are solid, supporting operations well into 2026. The company's strategic moves, including the Premier agreement and international partnerships, are expected to drive growth. While management's lack of specific details could be a concern, the overall sentiment is positive, with potential for stock price appreciation in the coming weeks.
XAIR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
